PIIGS nation may be transformed back into the "Celtic Tiger" it once was.

As the healthcare and technology hub of Europe, Irish stocks were some of the best performing European equities last year. Going forward, that trend should continue into the future as its high-tech economy is back in full swing. For investors looking for growth, often ignored Ireland could be their best play.

No More Bailouts

Before the Great Recession, data from investment bank Credit Suisse (NYSE:CS) showed that Ireland was actually the European Union's second wealthiest country in terms of GDP per capita. Unfortunately, major problems with the Irish financial system created a hyper-lending scenario that ultimately went bust as the global recession took hold. Irish real estate prices crashed and the nation had to take an €85 billion bailout from the International Monetary Fund and European Union. 

Well after three years, Ireland is finally back on track.

At the end of 2013, the nation was able to payback and emerge from underneath the bailout. Sky-high debts have been cut in half, joblessness has fallen, and business & consumer confidence has hit post-recession highs. And perhaps more importantly, GDP growth has once again returned. Overall, Ireland managed to expand its economy 0.3% in 2013, while estimations for 2014 and 2015’s GDP growth clock in at 1.7% in 2.5%, respectively.

The reason for this return to growth- aside from taking austerity measures in stride- has been the high-tech Irish economy.

Akin to Israel in the Middle East, Ireland has built its economic growth on becoming a technological and biomedical leader. Since the 1960’s, foreign companies have taken advantage of the nation's educated work force and lower corporate taxes. As such, Ireland is quickly becoming the biotech hub for all of Europe- with more than 170 companies in the pharmaceutical/chemical, biopharmaceuticals, medical devices and diagnostics industries within its borders. That number continues to grow as various economic incentive programs have made the nation a hot-bed of venture capital activity. 

All in all, the return to growth due to its high-tech economy helped push the Irish Stock Exchange upwards nearly 33% during 2013. 

Betting On The Emerald Isle

While the nation is still a work in progress, the recent successes point to a better picture for the high-tech economy. The Celtic Tiger is certainly roaring again and the broadest way to play it is through the iShares MSCI Ireland Capped (Nasdaq:EIRL).

The ETF spreads its $167 million in assets among 24 different Irish large- mid- and small-cap stocks. This includes the Bank of Ireland (NYSE:IRE) and sports book/gambling firm Paddy Power (OTCBB:PDYPF). Performance for the ETF has been amazing since the bail-out and returned a monster 47% last year. Expenses for the ETF run a relatively cheap 0.48%. Another broad bet on Ireland is the actively managed closed-end fund (CEF) –the New Ireland Fund (NYSE:IRL). IRL currently trades at 13% discount to its NAV

As we’ve mentioned before- biotech and healthcare is Ireland’s bread-n-butter. As such, the nation has a plethora of publicly traded drug firms. These include Alkermes (Nasdaq:ALKS) and Endo Health Solutions Inc. (Nasdaq:ENDP). However, two of the best could be Jazz Pharmaceuticals (Nasdaq:JAZZ) and Shire (Nasdaq:SHPG).

Aside from making the top selling ADHD drug Adderall- Shire has recently begun tackling more rare diseases and currently has drugs for ulcerative colitis and hereditary angioedema in its portfolio. Meanwhile, JAZZ has several lymphoblastic leukemia drugs in the works. These potential blockbusters should help propel JAZZ and SHPG higher. 

Just because Ireland has become a biotech leader, doesn’t mean it lacks a dose of industrial might as well. Diversified industrial giant Ingersoll-Rand (NYSE:IR) –along with its recent spin-off Allegion (Nasdaq:ALLE) –both are domiciled in the nation and have continued to see rising orders for its heavy machinery. Construction aggregate giant CRH (NYSE:CRH) has also seen rising revenues on the back of rising orders.

The Bottom Line

Ireland seems to be overcoming its fiscal woes as the nation’s tech story continues to drive its recovery and positive GDP growth. For investors, that could mean the time is right to snag-up shares of Irish stocks. The previous Irish picks- along with airplane leasing firm FLY Leasing Limited (NYSE:FLY)- make ideal buys.

Related Articles
  1. Insurance

    A Checklist For Successful Medical Technology Investment

    Find an investment that will give your portfolio a shot in the arm.
  2. Economics

    An Introduction To The PIIGS

    Learn which countries are included in the PIIGS and why they are grouped together.
  3. Personal Finance

    How PIIGS Defaults Could Affect The Markets

    What would a default by Europe's PIIGS do to the European and world financial markets, and how would the eurozone cope?
  4. Mutual Funds & ETFs

    Investing In The Healthcare Sector

    Perform a thorough checkup to uncover a medical stock with a clean bill of health.
  5. Active Trading

    The Ups And Downs Of Biotechnology

    This volatile sector can provide huges gains, but there's also lots of downside.
  6. Investing

    Time to Bring Active Back into a Portfolio?

    While stocks have rallied since the economic recovery in 2009, many active portfolio managers have struggled to deliver investor returns in excess.
  7. Chart Advisor

    Now Could Be The Time To Buy IPOs

    There has been lots of hype around the IPO market lately. We'll take a look at whether now is the time to buy.
  8. Personal Finance

    How Tech Can Help with 3 Behavioral Finance Biases

    Even if you’re a finance or statistics expert, you’re not immune to common decision-making mistakes that can negatively impact your finances.
  9. Chart Advisor

    Copper Continues Its Descent

    Copper prices have been under pressure lately and based on these charts it doesn't seem that it will reverse any time soon.
  10. Mutual Funds & ETFs

    Buying Vanguard Mutual Funds Vs. ETFs

    Learn about the differences between Vanguard's mutual fund and ETF products, and discover which may be more appropriate for investors.
  1. Should mutual funds be subject to more regulation?

    Mutual funds, when compared to other types of pooled investments such as hedge funds, have very strict regulations. In fact, ... Read Full Answer >>
  2. Do ETFs pay capital gains?

    Exchange-traded funds (ETFs) can generate capital gains that are transferred to shareholders, typically once a year, triggering ... Read Full Answer >>
  3. How do real estate hedge funds work?

    A hedge fund is a type of investment vehicle and business structure that aggregates capital from multiple investors and invests ... Read Full Answer >>
  4. Are Vanguard ETFs commission-free?

    While some Vanguard exchange-traded funds (ETFs) are available commission-free from third-party brokers, a large portion ... Read Full Answer >>
  5. Do Vanguard ETFs require a minimum investment?

    Vanguard completely waives any U.S. dollar minimum amounts to buy its exchange-traded funds (ETFs), and the minimum ETF investment ... Read Full Answer >>
  6. Can mutual fund expense ratios be negative?

    Mutual fund expense ratios cannot be negative. An expense ratio is the sum total of all fees charged by an asset management ... Read Full Answer >>

You May Also Like

Trading Center